rs121918021
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_000293.3(PHKB):c.1257T>A(p.Tyr419*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00011 in 1,612,040 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. Y419Y) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000293.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- glycogen storage disease IXbInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PHKB | NM_000293.3 | c.1257T>A | p.Tyr419* | stop_gained | Exon 13 of 31 | ENST00000323584.10 | NP_000284.1 | |
PHKB | NM_001363837.1 | c.1257T>A | p.Tyr419* | stop_gained | Exon 13 of 31 | NP_001350766.1 | ||
PHKB | NM_001031835.3 | c.1236T>A | p.Tyr412* | stop_gained | Exon 14 of 32 | NP_001027005.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152160Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000597 AC: 15AN: 251360 AF XY: 0.0000442 show subpopulations
GnomAD4 exome AF: 0.000114 AC: 167AN: 1459880Hom.: 0 Cov.: 29 AF XY: 0.000100 AC XY: 73AN XY: 726440 show subpopulations
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152160Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74336 show subpopulations
ClinVar
Submissions by phenotype
Glycogen storage disease IXb Pathogenic:2
This sequence change creates a premature translational stop signal (p.Tyr419*) in the PHKB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PHKB are known to be pathogenic (PMID: 9215682, 9326319). This variant is present in population databases (rs121918021, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with glycogen storage disease (PMID: 9215682). This variant is also known as Y418ter. ClinVar contains an entry for this variant (Variation ID: 13620). For these reasons, this variant has been classified as Pathogenic. -
- -
Glycogen phosphorylase kinase deficiency Pathogenic:1
Variant summary: PHKB c.1257T>A (p.Tyr419X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 6e-05 in 251360 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in PHKB causing Glycogen Phosphorylase Kinase Deficiency (6e-05 vs 0.0011), allowing no conclusion about variant significance. c.1257T>A has been reported in the literature in at least one compound heterozygous individual affected with Glycogen Phosphorylase Kinase Deficiency (e.g. Burwinkel_1997). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 9215682). ClinVar contains an entry for this variant (Variation ID: 13620). Based on the evidence outlined above, the variant was classified as pathogenic. -
PHKB-related disorder Pathogenic:1
The PHKB c.1236T>A variant is predicted to result in premature protein termination (p.Tyr412*). This variant, which is also described as c.1257T>A using alternate transcript NM_000293.2, has been reported in the compound heterozygous state with a second causative PHKB variant in two unrelated patients with glycogen storage disease type IXb (GSD IXb) (Burwinkel et al. 1997. PubMed ID: 9402963, referred to as Y418ter; Beauchamp et al. 2007. PubMed ID: 17689125). This variant is reported in 0.012% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Other premature protein termination variants in PHKB both up- and downstream of this variant have been reported to be causative of GSD IXb (Human Gene Mutation Database). This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at